Drugs · 2013 · 141 citations · 13 references
PharmacyPharmacologyPharmacotherapyBiopharmaceuticsClinical PharmacologyDrug Approval ProcessesDrug ApprovalEssential MedicinesInvestigational New Drug ApplicationsNew Drug ApplicationsPreclinical Safety EvaluationPost-approval Drug SafetyPost-market Drug Safety AnalysisPost-marketing Drug Safety Surveillance
13
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty, J. Infante, Adil Daud et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text
Medicine, Oncology, Pharmacology +16
Dennie T. Frederick, Adriano Piris, Alexandria P. Cogdill et al. · Clinical Cancer Research · 2013 · 938 citations · Full text
Life Sciences, Immunology, Oncology +17